特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
475129

世界の血管造影装置市場:2017~2021年

Global Angiography Devices Market 2017-2021

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 117 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.49円
世界の血管造影装置市場:2017~2021年
出版日: 2017年02月17日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 117 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

冠動脈疾患は心血管疾患のひとつで、世界的に主な死因となっています。治療のため、医師はバルーンカテーテルを用いた血管形成術を行ない、血流を促進します。CDCによると、冠動脈疾患が原因による死亡は年間370,000件と予測されています。世界の血管造影装置市場は2017~2021年にかけCAGR6.06%で拡大すると予測されています。

当レポートでは、世界の血管造影装置市場について調査し、市場の現状と将来見通し、製品別、エンドユーザー別、地域別動向、市場に参入する主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 製品別市場セグメンテーション

  • 血管形成バルーン市場
  • 血管閉鎖装置
  • 血管ガイドワイヤ
  • 塞栓保護装置

第7章 エンドユーザー別市場セグメンテーション

  • 外来外科センター
  • 病院
  • 診療所

第8章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第9章 市場促進因子

  • 心疾患の発症率上昇が血管造影装置の導入を拡大
  • 特殊心臓外科医の存在
  • 研究のCROへのアウトソース
  • 新規参入企業の市場参入のためのベンチャーキャピタル
  • 改良された医療用画像による低侵襲性処置

第10章 促進因子の影響

第11章 市場の課題

  • 血管造影装置および手技のコストの高さ
  • 製品リコール
  • 製品差別化の不足が利幅減に

第12章 促進因子と課題の影響

第13章 市場動向

第14章 ベンダー環境

  • 競合環境分析

第15章 主要ベンダー分析

  • Abbott Laboratories
  • Boston Scientific
  • Cardinal Health
  • Medtronic
  • 注目企業
  • その他の注目すべきベンダー

第16章 付録

第17章 Technavioについて

図表

図表
  • Exhibit 01: Product offerings
  • Exhibit 02: Global angiography devices market: Overview
  • Exhibit 03: Angioplasty devices market by product type 2016
  • Exhibit 04: Scope of angiography devices market based on geography 2017-2021
  • Exhibit 05: Global angiography devices market: Impact assessment
  • Exhibit 06: Global angiography devices market 2016-2021 ($ billions)
  • Exhibit 07: Few key market developments
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Global angiography devices market by product 2016-2021 ($ billions)
  • Exhibit 10: Market overview: Angioplasty balloon
  • Exhibit 11: Key focus and strategies of companies: Angioplasty balloon
  • Exhibit 12: Global angioplasty balloons market 2016-2021 ($ billions)
  • Exhibit 13: Clinical study: Difference in stenosis of DEBs
  • Exhibit 14: Market overview: Vascular closure device
  • Exhibit 15: Key focus and strategies of companies: Vascular closure device
  • Exhibit 16: Global vascular closure devices market 2016-2021 ($ billions)
  • Exhibit 17: Market overview and focus of companies: Vascular guidewire
  • Exhibit 18: Key focus and strategies of companies: Vascular guidewire
  • Exhibit 19: Global vascular guidewires market 2016-2021 ($ billions)
  • Exhibit 20: Market overview and focus of companies: Embolic protection device
  • Exhibit 21: Key focus and strategies of companies: Embolic protection device
  • Exhibit 22: Global embolic protection devices market 2016-2021 ($ billions)
  • Exhibit 23: Some advanced embolic protection devices
  • Exhibit 24: New entrants and milestone achieved by them
  • Exhibit 25: Embolic protection devices: Clinical studies with positive results
  • Exhibit 26: Global angiography devices market in 2016
  • Exhibit 27: Comparison of reimbursement for ASCs, hospital out-patient departments, and physicians' offices in US
  • Exhibit 28: Coronary angioplasty same day basis procedure in hospitals and ASCs in Europe
  • Exhibit 29: Global angiography devices market by geography in 2016 and 2021 ($ billions)
  • Exhibit 30: Market overview: Angiography devices market in Americas
  • Exhibit 31: Number of coronary angiography in few countries in Americas 2013
  • Exhibit 32: Angiography devices market in Americas 2016-2021 ($ billions)
  • Exhibit 33: Angiography devices market in Americas: Metrics analysis for various countries
  • Exhibit 34: Market overview: Angiography devices market in the US
  • Exhibit 35: Implements amended in ACA in US (in 2010 and 2014-2015)
  • Exhibit 36: Impact of Accountable Care Organization (ACO) and ACA on angiography devices
  • Exhibit 37: Market overview: Angiography devices market in EMEA
  • Exhibit 38: Number of coronary revascularization procedures per 100,000 people in various countries in EMEA 2013
  • Exhibit 39: Number of coronary angiography procedures in various countries in EMEA 2006 and 2013 (in 100,000 population)
  • Exhibit 40: Angiography devices market in EMEA 2016-2021 ($ billions)
  • Exhibit 41: Angiography devices market in EMEA: Metrics analysis by countries
  • Exhibit 42: Market overview: Angiography devices market in Israel
  • Exhibit 43: Market overview: Angiography devices market in APAC
  • Exhibit 44: Angiography devices market in APAC 2016-2021 ($ billions)
  • Exhibit 45: Market overview: Angiography devices market in India
  • Exhibit 46: CROs that helped companies receive regulatory approvals for PCI devices
  • Exhibit 47: CROs that helped companies receive regulatory approvals for PCI devices
  • Exhibit 48: New market entrants
  • Exhibit 49: Impact of drivers
  • Exhibit 50: Product recalls: Angiography devices
  • Exhibit 51: Impact of drivers and challenges
  • Exhibit 52: Marketing and sales strategies of large and small companies
  • Exhibit 53: Acquisitions by some companies
  • Exhibit 54: Competitive structure analysis of global angiography devices market 2016
  • Exhibit 55: Competitive landscape analysis of global angiography devices market 2016
  • Exhibit 56: Abbott Laboratories: Strength assessment
  • Exhibit 57: Abbott Laboratories: Strategy assessment
  • Exhibit 58: Abbott Laboratories: Opportunity assessment
  • Exhibit 59: Boston Scientific: Strength assessment
  • Exhibit 60: Boston Scientific: Strategy assessment
  • Exhibit 61: Boston Scientic: Opportunity assessment
  • Exhibit 62: Cardinal Health: Strength assessment
  • Exhibit 63: Cardinal Health: Strategy assessment
  • Exhibit 64: Cardinal Health: Opportunity assessment
  • Exhibit 65: Medtronic: Strength assessment
  • Exhibit 66: Medtronic: Strategy assessment
  • Exhibit 67: Medtronic: Opportunity assessment
  • Exhibit 68: Key companies to watch
  • Exhibit 69: Other prominent vendors
目次
Product Code: IRTNTR12035

About Angiography Devices

Coronary artery disease (CAD), a type of cardiovascular disease, is one of the leading causes of deaths worldwide, which is accounting for high number of heart attacks, stroke, and death. The formation of plaque in the blood vessels can cause CAD. The disease causes narrowing of the blood vessels, which interrupts normal blood flow and may lead to ischemic stroke. For treatment, physicians may perform angioplasty using balloon catheters with or without stents to open the arteries and improve the blood flow. These diseases are related to the heart and blood vessels. Coronary artery disease causes blockage in the artery characterized by the deposition of fatty substances that leads to the narrowing of blood vessels, and thereby interrupting the supply of normal blood flow to the heart. In an August 2015 report, the Centers of Disease Control and Prevention (CDC) estimated that coronary artery disease causes 370,000 deaths annually.

Technavio's analysts forecast the global angiography devices market to grow at a CAGR of 6.06% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global angiography devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of angiography devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Angiography Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Boston Scientific
  • Cardinal Health
  • Medtronic

Other Prominent Vendors

  • Abiomed
  • Aachen Resonance
  • Acrostak
  • Advansource Biomaterials
  • AGA Medical
  • Allium Medical
  • Alvimedica Medical devices
  • AMG International
  • Angioslide
  • AngioDynamics
  • Arstasis
  • Arthesys
  • Asahi Intecc
  • Atrium Medical
  • AV Medical
  • B. Braun Melsungen
  • Beijing Puyishengji Medical Technology
  • Biophan Technologies
  • Biosense Webster
  • Biotronik
  • BrosMed
  • Cardiac Science
  • CardiacAssist
  • Cardica
  • Cardio-Flow
  • Cardionovum
  • Claret Medical
  • Contego Medical
  • Cook Group
  • Cryolife
  • Endocor
  • Edward Lifesciences
  • Essential Medical
  • GaltNeedleTech
  • Kaneka Medix
  • InSeal Medical
  • Innovative Cardiovascular Solutions
  • JOTEC
  • Keystone Heart
  • Lepu Medical Technology
  • Medinol
  • Medeon Biodesign
  • Morris Innovative
  • Merit Medical Systems
  • Meril Life Sciences
  • MicroPort Scientific
  • Natec Medical
  • OptiMed
  • QT Vascular
  • SHOCKWAVE Medical
  • Smiths Medical
  • Spectranetics
  • STENTYS
  • Svelte medical
  • Teleflex
  • Tokai Medical
  • Transverse Medical
  • Transluminal Technologies
  • US Endovascular
  • Vascular Closure Systems
  • Vasorum
  • Vivasure Medical
  • Volcano

Market driver

  • Rising incidences of cardiac diseases increasing adoption of angiography devices
  • For a full, detailed list, view our report

Market challenge

  • Lack of product differentiation leading to marginal profits
  • For a full, detailed list, view our report

Market trend

  • Transforming marketing and sales strategies
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Angioplasty balloons market
  • Vascular closure device
  • Vascular guidewire
  • Embolic protection devices

PART 07: Market segmentation by end user

  • ASCs
  • Hospitals
  • Physicians' offices

PART 08: Geographical segmentation

  • Angiography devices market in Americas
  • Angiography devices market in EMEA
  • Angiography devices market in APAC

PART 09: Market drivers

  • Rising incidences of cardiac diseases increasing adoption of angiography devices
  • Presence of specialized cardiologists
  • Outsourcing research to CROs
  • Venture capitals for market entry of start-ups
  • Minimally invasive procedures with improved medical imaging

PART 10: Impact of drivers

PART 11: Market challenges

  • High cost of angiography devices and procedures
  • Product recalls
  • Lack of product differentiation leading to marginal profits

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Transforming marketing and sales strategies
  • Increase in M&A
  • Emergence of digital cath labs in hospitals

PART 14: Vendor landscape

  • Competitive landscape analysis

PART 15: Key vendor analysis

  • Abbott Laboratories
  • Boston Scientific
  • Cardinal Health
  • Medtronic
  • Key companies to watch
  • Other prominent vendors

PART 16: Appendix5

  • List of abbreviations

PART 17: Explore Technavio

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.